73030-39-4 Usage
Occurrence
Naturally occurring in plants (e.g., Peganum harmala) and animals (various species of insects)
Chemical Structure
Tricyclic compound with a fused pyridoindole core
Classification
Beta-carboline alkaloid
Psychoactive Properties
Yes, has been found to have psychoactive properties
Neurotransmitter Interaction
Modulates neurotransmitter systems in the brain, including serotonin and dopamine
Potential Role
Studied for its potential role in neurodegenerative diseases
Biomarker
Identified as a biomarker for certain neurological conditions
Research Interest
Pharmacological and toxicological properties are of interest to researchers in neuroscience, psychiatry, and pharmacology
This list provides a summary of the key characteristics and findings related to 1,2,3,4,12,12b-hexahydroindolo[2,3-a]quinolizin-7(6H)-one (tetrahydroharmane) as described in the material provided.
Check Digit Verification of cas no
The CAS Registry Mumber 73030-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,0,3 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 73030-39:
(7*7)+(6*3)+(5*0)+(4*3)+(3*0)+(2*3)+(1*9)=94
94 % 10 = 4
So 73030-39-4 is a valid CAS Registry Number.
73030-39-4Relevant academic research and scientific papers
Synthesis of 7-Oxo-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine
Tompkins, David C.,Nelson, Randall B.,Dolby, Lloyd J.,Gribble, Gordon W.
, p. 2168 - 2171 (2018/08/03)
A short synthesis of 7-oxo-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine from 2-acetylpyridine and phenylhydrazine is described. Ring C is forged using 2-chloro-N,N-dimethylacetamide. This derivative of the natural alkaloid 1,2,3,4,6,7,12,12b-octah
Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interaction
Jennings, Lee D.,Foreman, Ken W.,Rush III, Thomas S.,Tsao, Desiree H. H.,Mosyak, Lidia,Li, Yuanhong,Sukhdeo, Mohani N.,Ding, Weidong,Dushin, Elizabeth G.,Kenny, Cynthia Hess,Moghazeh, Soraya L.,Petersen, Peter J.,Ruzin, Alexey V.,Tuckman, Margareta,Sutherland, Alan G.
, p. 1427 - 1431 (2007/10/03)
The binding of FtsZ to ZipA is a potential target for antibacterial therapy. Based on a small molecule inhibitor of the ZipA-FtsZ interaction, a parallel synthesis of small molecules was initiated which targeted a key region of ZipA involved in FtsZ bindi
